(Aminobenzamidino)succinyl analogue

ID: ALA1160511

PubChem CID: 10472801

Max Phase: Preclinical

Molecular Formula: C17H22N4O4

Molecular Weight: 346.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C[C@H](CC(=O)O)NC(=O)CCC(=O)N(C)c1ccc(C(=N)N)cc1

Standard InChI:  InChI=1S/C17H22N4O4/c1-3-12(10-16(24)25)20-14(22)8-9-15(23)21(2)13-6-4-11(5-7-13)17(18)19/h3-7,12H,1,8-10H2,2H3,(H3,18,19)(H,20,22)(H,24,25)/t12-/m1/s1

Standard InChI Key:  HVGVVJWPNBZAHP-GFCCVEGCSA-N

Molfile:  

     RDKit          2D

 25 25  0  0  0  0  0  0  0  0999 V2000
   -0.8333   -3.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5792   -1.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7250   -3.7917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0250   -1.6875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3417    0.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8042    0.5833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0625   -1.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5625   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3625   -2.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9667   -0.7667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4375   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5750   -2.5000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0417   -1.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7167    1.1708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5917   -1.4917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0042   -0.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0042   -1.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6542   -2.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4583   -2.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1917   -3.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3958   -2.9917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0667   -1.1667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6000   -1.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3625    0.3708    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9292   -1.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  4  1  0
  3  1  2  0
  4  8  1  0
 11  5  1  1
  6  5  1  0
  7 23  1  0
  8 18  1  0
  9  1  1  0
 10  7  1  0
 11 10  1  0
 12  2  2  0
 13  2  1  0
 14  6  2  0
 15  7  2  0
 16 11  1  0
 17 19  1  0
 18 20  2  0
 19  9  2  0
 20  9  1  0
 21  1  1  0
 22 16  2  0
 23 13  1  0
 24  6  1  0
 25  4  1  0
 17  8  2  0
M  END

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 346.39Molecular Weight (Monoisotopic): 346.1641AlogP: 0.86#Rotatable Bonds: 9
Polar Surface Area: 136.58Molecular Species: ZWITTERIONHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 4.04CX Basic pKa: 11.49CX LogP: -1.90CX LogD: -1.90
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.30Np Likeness Score: -0.39

References

1. Zablocki JA, Rico JG, Garland RB, Rogers TE, Williams K, Schretzman LA, Rao SA, Bovy PR, Tjoeng FS, Lindmark RJ..  (1995)  Potent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (Aminobenzamidino)succinyl (ABAS) series of orally active fibrinogen receptor antagonists.,  38  (13): [PMID:7608903] [10.1021/jm00013a014]

Source